Literature DB >> 17977471

Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats.

Masao Sato1, Kazunori Uzu, Takeshi Yoshida, Essam M Hamad, Hiroshi Kawakami, Hiroaki Matsuyama, Ibrahim A Abd El-Gawad, Katsumi Imaizumi.   

Abstract

Despite adequate scientific evidence of the potential benefits of probiotics to human health or disease prevention, their contribution to the growth of adipose tissue remains to be established. Four-week-old male Sprague-Dawley rats were fed a diet containing skim milk (control diet) or skim milk fermented by Lactobacillus gasseri SBT2055 (LGSP diet) for 4 weeks. Their body weight gain, adipose tissue weight, adipocyte size distribution profile, blood and hepatic lipids, and serum leptin, glucose and adiponectin levels were determined. There was a significant reduction in average adipocyte size in mesenteric white adipose tissue (P = 0.004). Moreover, the rats fed the LGSP diet displayed greater numbers of small adipocytes from mesenteric and retroperitoneal adipose tissues than did those on the control diet. Whereas adiponectin concentrations did not differ between the groups, serum leptin concentrations were decreased to 32 % in the LGSP diet group compared with the control group. Concentrations of serum glucose and lipids, and liver lipids, except for the liver TAG level, were similar in the two groups. These results indicate a possible role for a fermented milk product in the regulation of adipose tissue growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977471     DOI: 10.1017/S0007114507839006

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  32 in total

Review 1.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

Review 2.  Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials.

Authors:  L Crovesy; M Ostrowski; D M T P Ferreira; E L Rosado; M Soares-Mota
Journal:  Int J Obes (Lond)       Date:  2017-07-10       Impact factor: 5.095

Review 3.  Gut microbiota and metabolic syndrome.

Authors:  Davide Festi; Ramona Schiumerini; Leonardo Henry Eusebi; Giovanni Marasco; Martina Taddia; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Effects of four Bifidobacteria on obesity in high-fat diet induced rats.

Authors:  Ya-Ni Yin; Qiong-Fen Yu; Nian Fu; Xiao-Wei Liu; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 5.  Gut microbiome and metabolic diseases.

Authors:  Shinji Fukuda; Hiroshi Ohno
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

6.  Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice.

Authors:  Masaya Miyoshi; Akihiro Ogawa; Satoshi Higurashi; Yukio Kadooka
Journal:  Eur J Nutr       Date:  2013-08-06       Impact factor: 5.614

Review 7.  Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties.

Authors:  Céline Druart; Maud Alligier; Nuria Salazar; Audrey M Neyrinck; Nathalie M Delzenne
Journal:  Adv Nutr       Date:  2014-09-15       Impact factor: 8.701

8.  Konjaku flour reduces obesity in mice by modulating the composition of the gut microbiota.

Authors:  Yongbo Kang; Yu Li; Yuhui Du; Liqiong Guo; Minghui Chen; Xinwei Huang; Fang Yang; Jingan Hong; Xiangyang Kong
Journal:  Int J Obes (Lond)       Date:  2018-09-21       Impact factor: 5.095

9.  Antiobesity Effect of Novel Probiotic Strains in a Mouse Model of High-Fat Diet-Induced Obesity.

Authors:  Chul Sang Lee; Mi Hyun Park; Byoung Kook Kim; Sae Hun Kim
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02-10       Impact factor: 4.609

10.  Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.

Authors:  Jasmine Bhathena; Christopher Martoni; Arun Kulamarva; Catherine Tomaro-Duchesneau; Meenakshi Malhotra; Arghya Paul; Aleksandra Malgorzata Urbanska; Satya Prakash
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.